Microparticles and nanoparticles as delivery systems for DNA vaccines.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Critical reviews in therapeutic drug carrier systems

• Publication date

  2003-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1615/CRITREVTHERDRUGCARRIERSYST.V20.I23.10PMID 14584521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Ethanol-in-Fluorocarbon Microemulsions for Topical Genetic Immunization

  2004cited by this paper
• The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.

  2003cited by this paper
• Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device.

  2003cited by this paper
• Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.

  2003cited by this paper
• Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice.

  2003cited by this paper
• Intranasal Gene Transfer by Chitosan–DNA Nanospheres Protects BALB/c Mice Against Acute Respiratory Syncytial Virus Infection

  2002cited by this paper
• A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens.

  2002cited by this paper
• Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen

  2002cited by this paper
• Intranasal administration of plasmid DNA‐coated nanoparticles results in enhanced immune responses

  2002cited by this paper
• Calcium Phosphate Nanoparticles Induce Mucosal Immunity and Protection against Herpes Simplex Virus Type 2

  2002cited by this paper
• INDUCTION OF A CYTOTOXIC T LYMPHOCYTE (CTL) RESPONSE TO PLASMID DNA DELIVERED VIA LIPODINE™ LIPOSOMES*

  2002cited by this paper
• Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein.

  2002cited by this paper
• Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.

  2002cited by this paper
• Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles.

  2002cited by this paper
• LIPOSOME (LIPODINE™)-MEDIATED DNA VACCINATION BY THE ORAL ROUTE

  2002cited by this paper
• Current status of DNA vaccines and their route of administration.

  2002cited by this paper
• Genetic Immunization Using Nanoparticles Engineered from Microemulsion Precursors

  2002cited by this paper
• A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines.

  2002cited by this paper
• Topical immunization using nanoengineered genetic vaccines.

  2002cited by this paper
• Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma.

  2002cited by this paper
• Dendritic cell delivery of plasmid DNA

  2001cited by this paper
• Liposome-mediated DNA vaccination: the effect of vesicle composition.

  2001cited by this paper
• Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

  2001cited by this paper
• Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes.

  2001cited by this paper
• Recent developments in adjuvants for vaccines against infectious diseases.

  2001cited by this paper
• DNA vaccination against respiratory influenza virus infection.

  2001cited by this paper
• Cationic Microparticles Are an Effective Delivery System for Immune Stimulatory CpG DNA

  2001cited by this paper
• Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines

  2001cited by this paper
• Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity.

  2001cited by this paper
• Chitosan and its derivatives in mucosal drug and vaccine delivery.

  2001cited by this paper
• Chitosan-based nanoparticles for topical genetic immunization.

  2001cited by this paper
• Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models.

  2000cited by this paper
• Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

  2000cited by this paper
• Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response.

  2000cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

  2000cited by this paper
• DNA vaccines: immunology, application, and optimization*.

  2000cited by this paper
• Calcium Phosphate Nanoparticle Adjuvant

  2000cited by this paper
• DNA vaccination: antigen presentation and the induction of immunity

  2000cited by this paper
• Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine.

  2000cited by this paper
• Recent developments in mucosal delivery of pDNA vaccines.

  2000cited by this paper
• DNA vaccines--challenges in delivery.

  2000cited by this paper
• Immunological concepts of vaccine adjuvant activity.

  2000cited by this paper
• Cationic microparticles: A potent delivery system for DNA vaccines.

  2000cited by this paper
• Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity.

  2000cited by this paper
• Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.

  2000cited by this paper
• Tissue Distribution and Persistence in Mice of Plasmid DNA Encapsulated in a PLGA-Based Microsphere Delivery Vehicle

  2000cited by this paper
• Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.

  1999cited by this paper
• Enhancement of DNA vaccine potency using conventional aluminum adjuvants.

  1999cited by this paper
• Immunization via hair follicles by topical application of naked DNA to normal skin

  1999cited by this paper
• DNA-based non-invasive vaccination onto the skin.

  1999cited by this paper
• Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

  1999cited by this paper
• Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

  1999cited by this paper
• Enhancement of mucosal immune responses to the influenza virus HA protein by alternative approaches to DNA immunization.

  1999cited by this paper
• Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2.

  1999cited by this paper
• PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization.

  1999cited by this paper
• Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

  1999cited by this paper
• Protective immunization against melanoma by gp100 DNA–HVJ-liposome vaccine

  1999cited by this paper
• Intradermal DNA immunization by using jet-injectors in mice and monkeys.

  1999cited by this paper
• Dendritic cells in genetic immunization

  1999cited by this paper
• Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.

  1998cited by this paper
• Improving protein therapeutics with sustained-release formulations

  1998cited by this paper
• Oral delivery of micro-encapsulated DNA vaccines.

  1998cited by this paper
• Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

  1998cited by this paper
• Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery.

  1998cited by this paper
• Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

  1998cited by this paper
• A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS.

  1998cited by this paper
• Fully mobilizing host defense: Building better vaccines

  1998cited by this paper
• Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles

  1998cited by this paper
• Preparation of Biodegradable, Surface Engineered PLGA Nanospheres with Enhanced Lymphatic Drainage and Lymph Node Uptake

  1997cited by this paper
• Cationic Liposomes Are a Strong Adjuvant for a DNA Vaccine of Human Immunodeficiency Virus Type 1

  1997cited by this paper
• Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.

  1997cited by this paper
• Liposome‐mediated DNA vaccination

  1997cited by this paper
• The mechanism of cholera toxin adjuvanticity.

  1997cited by this paper
• Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

  1997cited by this paper
• Vaccination onto bare skin

  1997cited by this paper
• Mucosal immunization with DNA-liposome complexes.

  1997cited by this paper
• The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites.

  1997cited by this paper
• The immunologist's grail: vaccines that generate cellular immunity.

  1997cited by this paper
• Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine

  1997cited by this paper
• HIV‐1‐specific cell‐mediated immune responses induced by DNA vaccination were enhanced by mannan‐coated liposomes and inhibited by anti‐interferon‐γ antibody

  1997cited by this paper
• Adjuvants--a classification and review of their modes of action.

  1997cited by this paper
• Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co‐polymers

  1997cited by this paper
• Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice.

  1997cited by this paper
• Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties.

  1997cited by this paper
• Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.

  1996cited by this paper
• DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity.

  1996cited by this paper
• Gene vaccination with naked plasmid DNA: mechanism of CTL priming

  1996cited by this paper
• Fusigenic viral liposome for gene therapy in cardiovascular diseases.

  1996cited by this paper
• Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation

  1996cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Biodegradable microspheres in drug delivery.

  1995cited by this paper
• Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.

  1994cited by this paper
• Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes

  1994cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

  1993cited by this paper
• Genetic immunization is a simple method for eliciting an immune response

  1992cited by this paper
• Freund's complete adjuvant: an effective but disagreeable formula.

  1992cited by this paper
• Liposomes as carriers of antigens and adjuvants.

  1991cited by this paper

• Electro-Osmotic Peristaltic Streaming of a Fractional Second-Grade Viscoelastic Nanofluid with Single and Multi-Walled Carbon Nanotubes in a Ciliated Tube

  2025cites this paper
• Green Synthesis, Chemical Characterization, Antioxidant, Cytotoxicity and Anticancer Effects of Vanadium Nanoparticles

  2024cites this paper
• A Focus on Biomaterials Based on Calcium Phosphate Nanoparticles: an Indispensable Tool for Emerging Biomedical Applications

  2023cites this paper
• Review on Needle Free Injection Technology

  2023cites this paper
• Nanovaccines to Combat Aeromonas hydrophila Infections in Warm-Water Aquaculture: Opportunities and Challenges

  2023cites this paper
• Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation

  2022cites this paper
• Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies

  2021cites this paper
• Nanoemulsion Delivery of Herbal Products: Prospects and Challenges

  2020cites this paper
• NANOPARTICLE A TARGETED DRUG DELIVERY SYSTEM: AN OVERVIEW

  2019cites this paper
• Enhancement of immune response of piglets to PCV-2 vaccine by porcine IL-2 and fusion IL-4/6 gene entrapped in chitosan nanoparticles.

  2018cites this paper
• Nanostructures hybrides Au/Semi-conducteur : investigation des effets plasmoniques en catalyse sous lumière visible

  2017cites this paper
• Calcium Phosphate Nanoparticles as Potent Adjuvant and Drug Delivery Agent

  2017cites this paper
• Cutaneous DNA Immunization: Enhancing Penetration by Hair Follicle Modification or Microneedle Application

  2017cites this paper
• Dendritic Cells Targeting and pH-Responsive Multi-layered Nanocomplexes for Smart Delivery of DNA Vaccines

  2017cites this paper
• Immunological Evaluation of Biodegradable Particle Based Nanoparticles Encapsulating OMP Antigen as Potential Vaccine Candidate

  2016cites this paper
• Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens

  2016influential citation
• DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.

  2016cites this paper
• Adjuvants and Delivery Methods: Current and Novel

  2016cites this paper
• Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses

  2016cites this paper
• THE IN VIVO STABILITY OF DIRECTLY INJECTED NAKED DNA AND CALCIUM PHOSPHATE CONJUGATED DNA INTO HENS

  2015cites this paper
• Cerium Oxide Nanoparticles and Its Cytotoxicity Human Lung Cancer Cells

  2015cites this paper
• Adjuvanted trimethyl chitosan based nanoparticle formulations to improve immunogenicity of DNA vaccines

  2015cites this paper
• pH-sensitive carbonate apatite nanoparticles as DNA vaccine carriers enhance humoral and cellular immunity.

  2014cites this paper
• Adjuvants in Fish Vaccines

  2014cites this paper
• Futuristic and potential phase of nanomedicine

  2014cites this paper
• Potential of Nanocarriers in Antigen Delivery: The Path to Successful Vaccine Delivery

  2014cites this paper
• Adjuvants and immunostimulants in fish vaccines: current knowledge and future perspectives.

  2013cites this paper
• Nanotechnological Approaches for Genetic Immunization

  2013cites this paper
• Nanoparticles as a carrier for protein and plasmid DNA vaccines in microneedle-mediated transcutaneous immunization

  2013cites this paper
• Nanotechnology: A Big Revolution from the Small World

  2013cites this paper
• DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases

  2013cites this paper
• Alginate Nanoparticles as a Promising Adjuvant and Vaccine Delivery System

  2013cites this paper
• Nanocarriers, nanovaccines, and nanobacteria as nanobiotechnological concerns in modern vaccines

  2013cites this paper
• Nanotecnologie: una grande rivoluzione che parte dal piccolo

  2013cites this paper
• Poly(ethylene glycol) shell-sheddable magnetic nanomicelle as the carrier of doxorubicin with enhanced cellular uptake.

  2013cites this paper
• Poly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptake.

  2013cites this paper
• Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection

  2012cites this paper
• Improvement Of The Immunity Of Piglets To PRRS Vaccine By A Porcine IL-4 And IL-6 Fusion Gene Encapsulated In Chitosan Nanoparticles

  2012cites this paper
• Preparation of calcium phosphate nanoparticles and evaluation of their effects on muscle cells of rat

  2012cites this paper
• Pharmaceutical Non-Viral Formulations for Gene Vaccines

  2012cites this paper
• Biodegradable synthetic polymers: Preparation, functionalization and biomedical application

  2012cites this paper
• Novel approaches toward the development of an oral post-exposure DNA vaccine for latent tuberculosis using Salmonella typhimurium ∆aroA vector

  2012cites this paper
• Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design.

  2011cites this paper
• Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen

  2011cites this paper
• Liposomes as drug delivery systems for the treatment of TB.

  2011cites this paper
• VACINAS:: PROGRESSOS E NOVOS DESAFIOS PARA O CONTROLE DE DOENÇAS IMUNOPREVENÍVEIS

  2011cites this paper
• Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles.

  2010cites this paper
• A Peptide-Based Platform for Displaying Antibodies to Engage T Cells

  2010cites this paper
• Enzymatic synthesis of poly-l-lactide-co-glycolide in the ionic liquid 1-butyl-3-methylimidazolium hexafluorophosphate

  2010cites this paper
• Application of calcium phosphate nanoparticles in biomedicine

  2010cites this paper
• Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity.

  2010cites this paper
• Molecular therapeutics of cancer by means of electroporation-based transfer of siRNAs and EBV-based expression vectors.

  2009cites this paper
• Overview of Nanoscience in the Environment

  2009cites this paper
• Mucosal Adjuvanticity of a Shigella Invasin Complex with DNA-Based Vaccines

  2009cites this paper
• Production of antibodies to Little cherry virus 1 coat protein by DNA prime and protein boost immunization.

  2009cites this paper
• Protonated nanoparticle surface governing ligand tethering and cellular targeting.

  2009cites this paper
• NANOTECHNOLOGY IN MEDICINE AND HEALTH SCIENCES

  2008cites this paper
• Nanomedicine: Application of Nanobiotechnology in Medical Practice

  2008cites this paper
• Non-viral gene transfection technologies for genetic engineering of stem cells.

  2008cites this paper
• The Handbook of Nanomedicine

  2008cites this paper
• Nanoscale Materials, Devices, and Systems for Chem.-Bio Sensors, Photonics, and Energy Generation and Storage

  2008cites this paper
• The present and future of nanotechnology in human health care.

  2007cites this paper
• Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential.

  2007cites this paper
• Preparation and Characterization of Innovative Protein-coated Poly(Methylmethacrylate) Core-shell Nanoparticles for Vaccine Purposes

  2007cites this paper
• Corneal gene therapy.

  2007cites this paper
• Nanoparticles in modern medicine: State of the art and future challenges

  2007cites this paper
• Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine.

  2007cites this paper
• Unusually large acrylamide induced effect on the droplet size in AOT/Brij30 water-in-oil microemulsions.

  2007cites this paper
• Recent advances in delivery systems for anti-HIV1 therapy

  2007cites this paper
• Nanoparticles and microparticles as vaccine-delivery systems

  2007cites this paper
• Chemical adjuvants for plasmid DNA vaccines.

  2007cites this paper
• Mannan‐mediated gene delivery for cancer immunotherapy

  2007cites this paper
• Nanotecnologia farmacêutica aplicada ao tratamento da malária

  2007cites this paper
• Nanotechnologies for Targeted Delivery of Drugs

  2007cites this paper
• Nanotecnologia farmacutica aplicada ao tratamento da malria

  2007cites this paper
• Silica–gelatin bio-hybrid and transparent nano-coatings through sol–gel technique

  2007cites this paper
• Nanomaterials for medical diagnosis and therapy

  2007cites this paper
• A novel fabrication method for submicron hydrogel particles loaded with protein drug

  2007cites this paper
• ON EMERGING AND NEWLY IDENTIFIED HEALTH RISKS ( SCENIHR ) modified Opinion ( after public consultation ) on The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies

  2006cites this paper
• DNA-Pharmaceuticals: Formulation and Delivery in Gene Therapy, DNA Vaccination and Immunotherapy

  2006cites this paper
• Immunization of experimental animals

  2006cites this paper
• DNA Vaccines Against Tuberculosis

  2006cites this paper
• Nanodiamond bullets and their biological targets

  2006cites this paper
• Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases.

  2006cites this paper
• Characterization of particles fabricated with poly(D,L-lactic-co-glycolic acid) and an ornithine–histidine peptide as carriers of oligodeoxynucleotide for delivery into primary dendritic cells

  2006cites this paper
• Lecithin-based cationic nanoparticles as a potential DNA delivery system.

  2006cites this paper
• Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives.

  2006cites this paper
• A practical approach to the use of nanoparticles for vaccine delivery.

  2006cites this paper
• Nano- and microparticles as adjuvants in vaccine design: success and failure is related to host natural antibodies.

  2006cites this paper
• Tissue engineering by modulated gene delivery.

  2006cites this paper
• Drug Delivery Systems

  2006cites this paper
• SiRNA drug delivery by biodegradable polymeric nanoparticles.

  2006cites this paper
• DRUG DELIVERY SYSTEMS

  2006cites this paper
• Gemini cationic surfactant-based delivery systems for non-invasive cutaneous gene therapy

  2006cites this paper
• Critical evaluation of the therapeutic potential of bassic acid incorporated in oil-in-water microemulsions and poly-d,l-lactide nanoparticles against experimental leishmaniasis

  2006cites this paper
• Nanomedicine: current status and future prospects

  2005cites this paper
• Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties.

  2005cites this paper
• Particulate delivery systems for vaccines.

  2005cites this paper
• pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery.

  2005cites this paper
• Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.

  2005cites this paper